Eli Lilly is dropping the development of three therapies that did not meet expectations, including a gene therapy acquired ...

A new generation of engineered immune cell destroys cancer cells in mice 1 as effectively as conventional CAR-T-cell ...

Monash University researchers, in collaboration with Harvard University, have discovered how to permanently "switch off" ...

The development of a brain tumor in a study participant led regulators to suspend a Hurler syndrome therapy in early testing ...

Study suggests that persistently activated ATF6α is a tumor driver, a potential stratification marker for immunotherapy response, and a therapeutic target for HCC.

Researchers discovered that targeting epigenetic proteins Menin and DOT1L can permanently silence cancer-driving genes. The ...

Patients will be able to find out whether they have genes linked to cancer using a world-leading tool developed by the NHS.

QIMR Berghofer scientists have discovered a cancer-fighting RNA molecule that could hold the key to a new way of treating the ...

By targeting a cancer-driving pathway at multiple steps, a triple therapy stopped pancreatic tumors from developing ...

An experimental drug combination was able to effectively treat pancreatic cancer in mouse models without tumor resistance.